Euro-Med Laboratories Phil., Inc. (PSE: EURO)

PSE: EURO Balance Sheet

Financials in millions PHP. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	932.03	881.35	615.72	554.5	508.42	1,096
Trading Asset Securities	202.01	202.01	190.6	173.39	224.03	252.15
Cash & Short-Term Investments	1,134	1,083	806.31	727.89	732.44	1,348
Cash Growth	90.76%	34.36%	10.77%	-0.62%	-45.66%	1.00%
Accounts Receivable	1,955	1,592	1,439	1,319	1,537	1,749
Other Receivables	46.94	111.52	43.87	44.07	38.84	34.49
Receivables	2,002	1,703	1,483	1,363	1,584	1,802
Inventory	1,785	1,693	1,537	1,264	1,396	1,165
Prepaid Expenses	310.04	321.84	317.88	296.64	335.8	217.92
Other Current Assets	179.93	334.27	283.44	259.4	263.87	256.97
Total Current Assets	5,411	5,135	4,428	3,911	4,312	4,790
Property, Plant & Equipment	4,872	4,961	4,961	5,052	4,986	4,769
Long-Term Investments	0.2	0.2	0.2	0.2	0.2	0.2
Other Intangible Assets	268.13	268.13	268.13	268.21	268.39	268.57
Long-Term Deferred Tax Assets	111.74	109.15	97.15	105.95	125.32	91.65
Long-Term Deferred Charges	10.76	21.07	38.79	51.44	84.36	130.2
Other Long-Term Assets	280.7	268.76	266.17	302.82	295.49	288.55
Total Assets	10,954	10,764	10,059	9,691	10,072	10,338
Accounts Payable	273.29	477.38	345.59	301.14	529.84	476.28
Accrued Expenses	86.69	104.6	69.31	85.39	192.46	168.3
Short-Term Debt	3,273	3,014	2,633	2,283	2,642	2,296
Current Portion of Long-Term Debt	98.42	209.75	184.3	195.08	353.63	482.57
Current Portion of Leases	55.51	58.6	60.82	49.18	37.78	36.77
Current Income Taxes Payable	40.92	51.64	31.18	22.8	56.98	93.84
Current Unearned Revenue	31.95	1.81	0.75	0.4	0.39	0.91
Other Current Liabilities	-	0.11	0.62	0.6	20.11	22.36
Total Current Liabilities	3,859	3,918	3,326	2,937	3,833	3,577
Long-Term Debt	687.52	666.91	663.62	788.75	459.89	994.85
Long-Term Leases	83.74	89.48	138.91	105.29	97.87	113.93
Total Liabilities	4,875	4,919	4,350	4,051	4,624	4,882
Common Stock	4,112	4,112	4,112	4,112	4,112	4,112
Additional Paid-In Capital	66.61	66.61	66.61	66.61	66.61	66.61
Retained Earnings	1,926	1,692	1,547	1,494	1,325	1,320
Comprehensive Income & Other	-25.15	-25.15	-16.52	-31.79	-55.6	-42.74
Shareholders' Equity	6,080	5,845	5,709	5,641	5,448	5,456
Total Liabilities & Equity	10,954	10,764	10,059	9,691	10,072	10,338
Total Debt	4,198	4,039	3,681	3,421	3,591	3,925
Net Cash (Debt)	-3,064	-2,956	-2,874	-2,693	-2,859	-2,577
Net Cash Per Share	-0.75	-0.72	-0.70	-0.65	-0.70	-0.63
Filing Date Shares Outstanding	4,112	4,112	4,112	4,112	4,112	4,112
Total Common Shares Outstanding	4,112	4,112	4,112	4,112	4,112	4,112
Working Capital	1,552	1,217	1,102	973.51	478.59	1,213
Book Value Per Share	1.48	1.42	1.39	1.37	1.32	1.33
Tangible Book Value	5,811	5,577	5,441	5,372	5,179	5,188
Tangible Book Value Per Share	1.41	1.36	1.32	1.31	1.26	1.26
Land	-	173.34	131.83	106.59	106.59	106.59
Buildings	-	2,981	2,816	2,777	2,552	2,351
Machinery	-	6,365	6,278	6,254	6,193	5,944

Source: S&P Capital IQ. Standard template. Financial Sources.